EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

OGA mutant aberrantly hydrolyzes O-GlcNAc modification from PDLIM7 to modulate p53 and cytoskeleton in promoting cancer cell malignancy

Chia-Wei Hu, Ao Wang iD, Dacheng Fan, Matthew Worth, Zhengwei Chen, Junfeng Huang, Jinshan Xie iD, John Macdonald, Lingjun Li iD, Jiaoyang Jiang iD

Proceedings of the National Academy of Sciences · 2024

DOI: 10.1073/pnas.2320867121 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2024. Verfasst von Chia-Wei Hu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Pharmaceutical Sciences Division, School of Pharmacy, University of Wisconsin-Madison, Madison, WI 53705. Hauptthemen laut MEDLINE: Tumor Suppressor Protein p53, LIM Domain Proteins, Cytoskeleton. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIGMS NIH HHS, NIH HHS, NIA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

O-GlcNAcase (OGA) is the only human enzyme that catalyzes the hydrolysis (deglycosylation) of O-linked beta- N -acetylglucosaminylation (O-GlcNAcylation) from numerous protein substrates. OGA has broad implications in many challenging diseases including cancer. However, its role in cell malignancy remains mostly unclear. Here, we report that a cancer-derived point mutation on the OGA’s noncatalytic stalk domain aberrantly modulates OGA interactome and substrate deglycosylation toward a specific set of proteins. Interestingly, our quantitative proteomic studies uncovered that the OGA stalk domain mutant preferentially deglycosylated protein substrates with +2 proline in the sequence relative to the O-GlcNAcylation site. One of the most dysregulated substrates is PDZ and LIM domain protein 7 (PDLIM7), which is associated with the tumor suppressor p53. We found that the aberrantly deglycosylated PDLIM7 suppressed p53 gene expression and accelerated p53 protein degradation by promoting the complex formation with E3 ubiquitin ligase MDM2. Moreover, deglycosylated PDLIM7 significantly up-regulated the actin-rich membrane protrusions on the cell surface, augmenting the cancer cell motility and aggressiveness. These findings revealed an important but previously unappreciated role of OGA’s stalk domain in protein substrate recognition and functional modulation during malignant cell progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor Suppressor Protein p53LIM Domain ProteinsCytoskeletonHumansAcetylglucosamineNeoplasmsCell Line, TumorGlycosylationHydrolysisMutationCell MovementAntigens, NeoplasmHyaluronoglucosaminidaseHistone Acetyltransferases

Stichwörter der Autor:innen

O-GlcNAcaseO-GlcNAcylationPDLIM7cancerdeglycosylation

Substanzen

Tumor Suppressor Protein p53LIM Domain ProteinsAcetylglucosamineTP53 protein, humanOGA protein, humanAntigens, NeoplasmHyaluronoglucosaminidaseHistone Acetyltransferases

Autor:innen und Institutionen

  • Pharmaceutical Sciences Division, School of Pharmacy, University of Wisconsin-Madison, Madison, WI 53705.
  • Department of Chemistry, University of Wisconsin-Madison, Madison, WI 53706.

ORCID-Profile: Ao Wang, Jinshan Xie, Lingjun Li, Jiaoyang Jiang

Förderung

  • NIGMS NIH HHS
  • NIH HHS
  • NIA NIH HHS
  • HHS | NIH | National Institute on Aging (NIA)
  • NIDDK NIH HHS
  • NCRR NIH HHS
  • HHS | NIH | National Institute of General Medical Sciences (NIGMS)
  • HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases

Zitieren

APA

Hu, C. W., Wang, A., Fan, D., Worth, M., Chen, Z., Huang, J., Xie, J., Macdonald, J., Li, L., & Jiang, J. (2024). OGA mutant aberrantly hydrolyzes O-GlcNAc modification from PDLIM7 to modulate p53 and cytoskeleton in promoting cancer cell malignancy. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2320867121

Vancouver

Hu CW, Wang A, Fan D, Worth M, Chen Z, Huang J, et al. OGA mutant aberrantly hydrolyzes O-GlcNAc modification from PDLIM7 to modulate p53 and cytoskeleton in promoting cancer cell malignancy. Proceedings of the National Academy of Sciences. 2024. doi:10.1073/pnas.2320867121

BibTeX
@article{Hu2024,
  author = {Hu, Chia-Wei and Wang, Ao and Fan, Dacheng and Worth, Matthew and Chen, Zhengwei and Huang, Junfeng and Xie, Jinshan and Macdonald, John and Li, Lingjun and Jiang, Jiaoyang},
  title = {OGA mutant aberrantly hydrolyzes O-GlcNAc modification from PDLIM7 to modulate p53 and cytoskeleton in promoting cancer cell malignancy},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2024},
  doi = {10.1073/pnas.2320867121}
}
Kostenlos starten →